A systematic review of artificial intelligence-powered (AI-powered) chatbot intervention for managing chronic illness

References

• Hajat C, Stein E. The global burden of multiple chronic conditions: a narrative review. Prev Med Rep. 2018;12:1–14. doi: 10.1016/j.pmedr.2018.10.008.
   PubMedGoogle Scholar
• Schachner T, Keller R, Wangenheim FV. Artificial intelligence-based conversational agents for chronic conditions: systematic literature review. J Med Internet Res. 2020;22(9):e20701. doi: 10.2196/20701.
   PubMed Web of Science ®Google Scholar
• Holman HR. The relation of the chronic disease epidemic to the health care crisis. ACR Open Rheumatol. 2020;2(3):167–173. doi: 10.1002/acr2.11114.
   PubMedGoogle Scholar
• Papagiannidis S, Harris J, Morton D. WHO led the digital transformation of your company? A reflection of IT related challenges during the pandemic. Int J Inf Manage. 2020;55:102166. doi: 10.1016/j.ijinfomgt.2020.102166.
   PubMed Web of Science ®Google Scholar
• Nadarzynski T, Miles O, Cowie A, et al. Acceptability of artificial intelligence (AI)-led chatbot services in healthcare: a mixed-methods study. Digit Health. 2019;5:2055207619871808. doi: 10.1177/2055207619871808.
   Web of Science ®Google Scholar
• Allouch M, Azaria A, Azoulay R. Conversational agents: goals, technologies, vision and challenges. Sensors. 2021;21(24):8448. doi: 10.3390/s21248448.
   PubMed Web of Science ®Google Scholar
• Kocaballi AB, Quiroz JC, Rezazadegan D, et al. Responses of conversational agents to health and lifestyle prompts: investigation of appropriateness and presentation structures. J Med Internet Res. 2020;22(2):e15823. doi: 10.2196/15823.
   PubMed Web of Science ®Google Scholar
• Montenegro JLZ, da Costa CA, da Rosa Righi R. Survey of conversational agents in health. Expert Syst Appl. 2019;129:56–67. doi: 10.1016/j.eswa.2019.03.054.
   Web of Science ®Google Scholar
• Suta P, Lan X, Wu B, et al. An overview of machine learning in chatbots. Int J Mech Eng Robot Res. 2020;9:502–510. doi: 10.18178/ijmerr.9.4.502-510.
   Google Scholar
• Guzman AL, Lewis SC. Artificial intelligence and communication: a human–machine communication research agenda. New Media Soc. 2020;22(1):70–86. doi: 10.1177/1461444819858691.
   Web of Science ®Google Scholar
• Ivanov S, Webster C. Economic fundamentals of the use of robots, artificial intelligence, and service automation in travel, tourism, and hospitality. Ivanov, S. and Webster, C. (Ed.). In: Robots, artificial intelligence, and service automation in travel, tourism and hospitality. Emerald Publishing Limited; 2019. p. 39–55. doi: https://doi.org/10.1108/978-1-78756-687-320191017.
   Google Scholar
• Bickmore TW, Kimani E, Trinh H, et al. Managing chronic conditions with a smartphone-based conversational virtual agent. In: Proceedings of the 18th International Conference on Intelligent Virtual Agents. New York (NY): Association for Computing Machinery; 2018. p. 119–124. doi: 10.1145/3267851.3267908.
   Google Scholar
• Pereira J, Díaz Ó. Using health chatbots for behavior change: a mapping study. J Med Syst. 2019;43(5):135. doi: 10.1007/s10916-019-1237-1.
   PubMed Web of Science ®Google Scholar
• Greer S, Ramo D, Chang Y-J, et al. Use of the chatbot “vivibot” to deliver positive psychology skills and promote well-being among young people after cancer treatment: randomized controlled feasibility trial. JMIR Mhealth Uhealth. 2019;7(10):e15018. doi: 10.2196/15018.
   PubMed Web of Science ®Google Scholar
• Xu L, Sanders L, Li K, et al. Chatbot for health care and oncology applications using artificial intelligence and machine learning: systematic review. JMIR Cancer. 2021;7(4):e27850. doi: 10.2196/27850.
   PubMed Web of Science ®Google Scholar
• Griffin AC, Xing Z, Khairat S, et al. Conversational agents for chronic disease self-management: a systematic review. AMIA Annu Symp Proc. 2020;2020:504–513.
   PubMedGoogle Scholar
• Kang J, Thompson RF, Aneja S, et al. National Cancer Institute Workshop on artificial intelligence in radiation oncology: training the next generation. Pract Radiat Oncol. 2021;11(1):74–83. doi: 10.1016/j.prro.2020.06.001.
   PubMed Web of Science ®Google Scholar
• McGreevey JD, Hanson CW, Koppel R. Conversational agents in health care—reply. JAMA. 2020;324(23):2444–2445. doi: 10.1001/jama.2020.21518.
   PubMed Web of Science ®Google Scholar
• Laranjo L, Dunn AG, Tong HL, et al. Conversational agents in healthcare: a systematic review. J Am Med Inform Assoc. 2018;25(9):1248–1258. doi: 10.1093/jamia/ocy072.
   PubMed Web of Science ®Google Scholar
• Bendig E, Erb B, Schulze-Thuesing L, et al. The next generation: chatbots in clinical psychology and psychotherapy to foster mental health – a scoping review. Verhaltenstherapie. 2022;32(Suppl. 1):64–76. doi: 10.1159/000501812.
   Google Scholar
• Bin Sawad A, Narayan B, Alnefaie A, et al. A systematic review on healthcare artificial intelligent conversational agents for chronic conditions. Sensors. 2022;22(7):2625. doi: 10.3390/s22072625.
   PubMed Web of Science ®Google Scholar
• Robinson NL, Cottier TV, Kavanagh DJ. Psychosocial health interventions by social robots: systematic review of randomized controlled trials. J Med Internet Res. 2019;21(5):e13203. doi: 10.2196/13203.
   PubMed Web of Science ®Google Scholar
• Abd-Alrazaq AA, Rababeh A, Alajlani M, et al. Effectiveness and safety of using chatbots to improve mental health: systematic review and meta-analysis. J Med Internet Res. 2020;22(7):e16021. doi: 10.2196/16021.
   PubMed Web of Science ®Google Scholar
• Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350(1):g7647. doi: 10.1136/bmj.g7647.
   PubMedGoogle Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s Tool for assessing risk of bias in randomised trials. BMJ. 2011;343(2):d5928. doi: 10.1136/bmj.d5928.
   PubMed Web of Science ®Google Scholar
• Al-Hilli Z, Noss R, Dickard J, et al. A randomized trial comparing the effectiveness of pre-test genetic counseling using an artificial intelligence automated chatbot and traditional in-person genetic counseling in women newly diagnosed with breast cancer. Ann Surg Oncol. 2023;30(10):5997–5998. doi: 10.1245/s10434-023-13888-4.
   Web of Science ®Google Scholar
• Bibault J-E, Chaix B, Guillemassé A, et al. A chatbot versus physicians to provide information for patients with breast cancer: blind, randomized controlled noninferiority trial. J Med Internet Res. 2019;21(11):e15787. doi: 10.2196/15787.
   PubMed Web of Science ®Google Scholar
• Echeazarra L, Pereira J, Saracho R. TensioBot: a chatbot assistant for self-managed in-house blood pressure checking. J Med Syst. 2021;45(4):54. doi: 10.1007/s10916-021-01730-x.
   PubMed Web of Science ®Google Scholar
• Gong E, Baptista S, Russell A, et al. My diabetes coach, a mobile app-based interactive conversational agent to support type 2 diabetes self-management: randomized effectiveness-implementation trial. J Med Internet Res. 2020;22(11):e20322. doi: 10.2196/20322.
   PubMed Web of Science ®Google Scholar
• Hauser-Ulrich S, Künzli H, Meier-Peterhans D, et al. A smartphone-based health care chatbot to promote self-management of chronic pain (SELMA): pilot randomized controlled trial. JMIR Mhealth Uhealth. 2020;8(4):e15806. doi: 10.2196/15806.
   PubMed Web of Science ®Google Scholar
• Hunt M, Miguez S, Dukas B, et al. Efficacy of Zemedy, a mobile digital therapeutic for the self-management of irritable bowel syndrome: crossover randomized controlled trial. JMIR Mhealth Uhealth. 2021;9(5):e26152. doi: 10.2196/26152.
   PubMed Web of Science ®Google Scholar
• Tawfik E, Ghallab E, Moustafa A. A nurse versus a chatbot – the effect of an empowerment program on chemotherapy-related side effects and the self-care behaviors of women living with breast cancer: a randomized controlled trial. BMC Nurs. 2023;22(1):102. doi: 10.1186/s12912-023-01243-7.
   PubMed Web of Science ®Google Scholar
• Posadzki P, Mastellos N, Ryan R, et al. Automated telephone communication systems for preventive healthcare and management of long-term conditions. Cochrane Database Syst Rev. 2016;12(12):CD009921. doi: 10.1002/14651858.CD009921.pub2.
   PubMedGoogle Scholar
• López-Cózar R, Callejas Z, Espejo G, et al. Enhancement of conversational agents by means of multimodal interaction. In: Perez-Marin D, Pascual-Nieto I (editors). Conversational agents and natural language interaction. IGI Global; 2011. p. 223–252. doi: 10.4018/978-1-60960-617-6.ch010.
   Google Scholar
• Radziwill NM, Benton MC. Evaluating quality of chatbots and intelligent conversational agents. arXiv, abs/1704.04579; 2017.
   Google Scholar
• Young S, Gasic M, Thomson B, et al. POMDP-based statistical spoken dialog systems: a review. Proc IEEE. 2013;101(5):1160–1179. doi: 10.1109/JPROC.2012.2225812.
   Web of Science ®Google Scholar
• Aggarwal A, Tam CC, Wu D, et al. Artificial intelligence-based chatbots for promoting health behavioral changes: systematic review. J Med Internet Res. 2023;25:e40789. doi: 10.2196/40789.
   PubMedGoogle Scholar
• Bedi G, Carrillo F, Cecchi GA, et al. Automated analysis of free speech predicts psychosis onset in high-risk youths. NPJ Schizophr. 2015;1(1):15030. doi: 10.1038/npjschz.2015.30.
   PubMedGoogle Scholar
• Nishida T, Nakazawa A, Ohmoto Y, et al. Conversational informatics. Japan: Springer; 2014.
   Google Scholar
• Cabitza F, Rasoini R, Gensini GF. Unintended consequences of machine learning in medicine. JAMA. 2017;318(6):517–518. doi: 10.1001/jama.2017.7797.
   PubMed Web of Science ®Google Scholar
• Crawford K, Calo R. There is a blind spot in AI research. Nature. 2016;538(7625):311–313. doi: 10.1038/538311a.
   PubMed Web of Science ®Google Scholar